LSBio
CD63 Antibody

Western blot. Anti-CD63 antibody at 1:1000 dilution. Lysate at 50 ug per lane. Rabbit polyclonal to goat IgG (HRP) at 1:10000 dilution.

CD63 Antibody

Primary AntibodyLSBio Guarantee
Antibody:Goat Polyclonal
Applications:Immunofluorescence, Immunohistochemistry (general), Western Blot
Reactivity:Dog, Human, Mouse, Non-Human Primate, Rat
Format:Liquid
See all Human CD63 antibodies →
$431.00each
Catalog Number: LS-C204227-600

For bulk orders or custom formulations:

Request a Quote

Overview

Description
CD63 antibody LS-C204227 is an unconjugated goat polyclonal antibody to CD63 from human. It is reactive with human, mouse, rat and other species. Validated for IF and WB. Cited in 2 publications.
Application
IF, IHC, WB
Reactivity
Can, Hu, Ms, NHP, Rt
Intended Use
RUO
Guarantees
This antibody carries the LSBio 100% Guarantee. ✓
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
CD63 molecule | LAMP-3 | ME491 | Granulophysin | MLA1 | Tetraspanin-30 | Tspan-30 | CD63 | CD63 antigen | OMA81H | TSPAN30
Recommended Dilution: IF/ICC
1:25 - 1:250
Recommended Dilution: WB
1:500 - 1:5000
UniProt Number
P08962
SwissProt
P08962

Target

Target
Human CD63
Antigen Species
Hu
Epitope
Reacts with CD63, a 40-60 kDa glycoprotein, detected by Western blot in the following human (HeLa, HUH, Jurkat), mouse (AtT-20, Hepa, 3T3, RAW264.7), canine (MDCK) and monkey (COS-7) whole cell lysates.
Gene Name
CD63

Antibody

Host Species
Gt
Clonality
Polyclonal
Isotype
IgG

Immunogen

Immunogen
Purified recombinant peptide derived from within residues 120 aa to 175 aa of human CD63 produced in E. coli.
Immunogen Type
Frag-RP

Format

Conjugate/Label
Unconj
Format
Liquid
Formulation
PBS, 0.05% Sodium Azide, 20% Glycerol
Concentration
3 mg/mL
Preservative
Yes
Purification Method
AP

Storage & Handling

Storage Conditions
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes. Akira Sobue, Norimichi Ito, Taku Nagai, Wei Shan, Kazuhiro Hada, Akira Nakajima, Yuki Murakami, Akihiro Mouri, Yasuko Yamamoto, Toshitaka Nabeshima, Kuniaki Saito, Kiyofumi Yamada. Glia. 2018 May;66:1034-1052. PubMed: 29380419

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.